What is Omeros's stock-based comp?

Omeros (OMER) reported stock-based comp of $1.89M in Q1 2026.

How has Omeros's stock-based comp changed year-over-year?

Omeros's stock-based comp decreased by 23.0% year-over-year, from $2.45M to $1.89M.

What is the long-term trend for Omeros's stock-based comp?

Over 4 years (2021 to 2025), Omeros's stock-based comp has grown at a -17.4% compound annual growth rate (CAGR), from $17.63M to $8.19M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Omeros OMER Stock-Based Comp

Stock-Based Comp at other companies

Cullinan Therapeutics, Inc.CGEM

$7.62M-18.8%

Nektar TherapeuticsNKTR

$3.36M-13.9%

ImmunomeIMNM

$7.95M+39.5%

Vor BiopharmaVOR

$8.87M+359%

AnnexonANNX

$4.16M-18.2%

Arcus BiosciencesRCUS

$19M+18.8%

Other financials

Income statement

See full

Revenue$9.9M—

Gross profit$29.7M—

Operating income-$40.9M-9.2%

Net income$56.1M+268%

EPS (diluted)-$0.59-20.4%

Balance sheet

See full

Cash & equivalents$1.9M-55.3%

Total debt$13.5M-30.3%

Total equity-$63.3M+70.3%

Total assets$286.2M+21.7%

Cash flow

See full

Operating cash flow-$14.5M+59.5%

CapEx--100%

Free cash flow-$14.5M+59.6%

Valuation

See full

Market cap$775.86M+313%

P/S8.6×—

Profitability

See full

Gross margin98.9%—

Operating margin-181.8%—

Net margin-136.6%—

FCF margin-121.6%—

Returns & leverage

See full

Return on equity86.6%—

Debt / equity0.3×-1.1×

Current ratio3×+1.9×

Where this comes from

Reported directly by Omeros in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Omeros’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omeros's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omeros's stock-based comp?: Omeros (OMER) reported stock-based comp of $1.89M in Q1 2026.
How has Omeros's stock-based comp changed year-over-year?: Omeros's stock-based comp decreased by 23.0% year-over-year, from $2.45M to $1.89M.
What is the long-term trend for Omeros's stock-based comp?: Over 4 years (2021 to 2025), Omeros's stock-based comp has grown at a -17.4% compound annual growth rate (CAGR), from $17.63M to $8.19M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.